X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with Orchid Chemicals - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs ORCHID PHARMA LTD - Comparison Results

ORCHID PHARMA LTD 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB ORCHID PHARMA LTD UNICHEM LAB/
ORCHID PHARMA LTD
 
P/E (TTM) x 32.6 -0.6 - View Chart
P/BV x 3.4 0.4 768.0% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 UNICHEM LAB   ORCHID PHARMA LTD
EQUITY SHARE DATA
    UNICHEM LAB
Mar-16
ORCHID PHARMA LTD
Sep-13
UNICHEM LAB/
ORCHID PHARMA LTD
5-Yr Chart
Click to enlarge
High Rs334194 172.2%   
Low Rs17435 497.1%   
Sales per share (Unadj.) Rs146.9276.5 53.1%  
Earnings per share (Unadj.) Rs11.9-79.2 -15.0%  
Cash flow per share (Unadj.) Rs16.2-43.5 -37.3%  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs105.153.9 194.9%  
Shares outstanding (eoy) m90.8470.45 128.9%   
Bonus/Rights/Conversions ESOPESOP-  
Price / Sales ratio x1.70.4 417.5%   
Avg P/E ratio x21.4-1.4 -1,477.4%  
P/CF ratio (eoy) x15.7-2.6 -595.5%  
Price / Book Value ratio x2.42.1 113.8%  
Dividend payout %16.80-   
Avg Mkt Cap Rs m23,0738,067 286.0%   
No. of employees `0005.72.8 202.6%   
Total wages/salary Rs m2,5582,527 101.2%   
Avg. sales/employee Rs Th2,352.56,956.1 33.8%   
Avg. wages/employee Rs Th450.9902.5 50.0%   
Avg. net profit/employee Rs Th190.4-1,993.0 -9.6%   
INCOME DATA
Net Sales Rs m13,34619,477 68.5%  
Other income Rs m192407 47.1%   
Total revenues Rs m13,53819,884 68.1%   
Gross profit Rs m1,6391,103 148.6%  
Depreciation Rs m3902,519 15.5%   
Interest Rs m295,227 0.6%   
Profit before tax Rs m1,412-6,236 -22.6%   
Minority Interest Rs m020 0.0%   
Prior Period Items Rs m-40-   
Extraordinary Inc (Exp) Rs m-35511 -6.9%   
Tax Rs m293-125 -233.8%   
Profit after tax Rs m1,080-5,580 -19.4%  
Gross profit margin %12.35.7 216.9%  
Effective tax rate %20.72.0 1,032.5%   
Net profit margin %8.1-28.7 -28.3%  
BALANCE SHEET DATA
Current assets Rs m5,97911,014 54.3%   
Current liabilities Rs m2,43232,060 7.6%   
Net working cap to sales %26.6-108.1 -24.6%  
Current ratio x2.50.3 715.7%  
Inventory Days Days6395 66.5%  
Debtors Days Days6034 179.9%  
Net fixed assets Rs m6,40329,440 21.7%   
Share capital Rs m182705 25.8%   
"Free" reserves Rs m9,2932,043 454.9%   
Net worth Rs m9,5483,800 251.3%   
Long term debt Rs m2309,018 2.6%   
Total assets Rs m12,84346,510 27.6%  
Interest coverage x50.0-0.2 -25,906.8%   
Debt to equity ratio x02.4 1.0%  
Sales to assets ratio x1.00.4 248.1%   
Return on assets %8.6-0.8 -1,136.3%  
Return on equity %11.3-146.9 -7.7%  
Return on capital %14.3-3.7 -383.9%  
Exports to sales %29.237.9 77.1%   
Imports to sales %6.322.6 28.0%   
Exports (fob) Rs m3,9007,378 52.9%   
Imports (cif) Rs m8474,406 19.2%   
Fx inflow Rs m4,3567,513 58.0%   
Fx outflow Rs m1,1625,649 20.6%   
Net fx Rs m3,1941,865 171.3%   
CASH FLOW
From Operations Rs m1,1191,682 66.5%  
From Investments Rs m-853-9,860 8.7%  
From Financial Activity Rs m-3346,644 -5.0%  
Net Cashflow Rs m-68-1,535 4.4%  

Share Holding

Indian Promoters % 50.1 32.3 155.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 4.6 328.3%  
FIIs % 3.0 3.3 90.9%  
ADR/GDR % 0.0 4.6 -  
Free float % 31.7 55.3 57.3%  
Shareholders   20,176 84,811 23.8%  
Pledged promoter(s) holding % 0.0 54.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   PFIZER  GSK PHARMA  PANACEA BIOTECH  WYETH LTD  ABBOTT INDIA  

Compare UNICHEM LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Near Record High; Realty Stocks Bleed(Closing)

After opening the day on a strong note, share markets in India witnessed volatility during the last hour of trading session. However, they managed to end the day on a positive note.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

The ONLY Thing You Need to Know About Bitcoin(The 5 Minute Wrapup)

Jan 6, 2018

You either want it or you want to get as far away from it as possible - but Bitcoin is just the noise masking the REAL opportunity. Read about it here...

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Jan 18, 2018 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB - AJANTA PHARMA COMPARISON

COMPARE UNICHEM LAB WITH

MARKET STATS